CCO Infectious Disease Podcast

Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Audio Recap

Episode Summary

Listen to expert insights from Stefan Zeuzem, MD, on updates and new viral hepatitis data from EASL 2022, including novel therapeutics for HBV, HBV cure data, therapeutic updates for HDV, and HCV treatment for treatment-experienced patients.

Episode Notes

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from EASL 2022, including:

• Novel HBV therapeutics, including the REEF-2, B-Clear, and SAVE-1 studies
• HBV cure from the Everest Project in China
• HDV therapeutics from MYR301 and a study of bulevirtide in patients with cirrhosis and portal hypertension
• HCV retreatment in patients with prior direct-acting antiviral therapy failure

Presenter: 

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I 
JW Goethe University Hospital 
Frankfurt, Germany

Follow along with the downloadable slideset at:
https://bit.ly/3yJAruD

Link to full program: 
https://bit.ly/3AjCNBC